Duration of the anti-Androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death

N. N. Sanford, M. H. Chen, M. Loffredo, A. Renshaw, P. W. Kantoff, A. V. D'Amico

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Duration of the anti-Androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death'. Together they form a unique fingerprint.

Medicine & Life Sciences